Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism

被引:54
作者
Chiodini, I
Tauchmanovà, L
Torlontano, M
Battista, C
Guglielmi, G
Cammisa, M
Colao, A
Carnevale, V
Rossi, R
Di Lembo, S
Trischitta, V
Scillitani, A
机构
[1] Sci Inst Casa Sollievo Sofferenza, Endocrine Unit, I-71013 San Giovanni Rotondo, Foggia, Italy
[2] Sci Inst Casa Sollievo Sofferenza, Radiol Unit, I-71013 San Giovanni Rotondo, Foggia, Italy
[3] Sci Inst Casa Sollievo Sofferenza, Unit Internal Med, I-71013 San Giovanni Rotondo, Foggia, Italy
[4] San Giuseppe Fatebenefratelli Hosp, Unit Endocrinol, Fatebenefratelli Assoc Res, I-20123 Milan, Italy
[5] Univ Naples Federico II, Unit Endocrinol, I-80129 Naples, Italy
[6] Univ Roma La Sapienza, Dept Clin Sci, I-00498 Rome, Italy
关键词
D O I
10.1210/jc.2002-020399
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Adrenal incidentalomas (AI) are not associated, by definition, with clinically evident syndromes; however, some AI patients may show biochemical indexes of subclinical hypercortisolism. (SH). Previous data on female AI patients indicated that SH may lead to bone loss, at least at spine. No data are available on bone involvement in samples of only AI male patients. We measured bone metabolism and bone mineral density at spine and femur by dual-energy x-ray absorptiometry in 38 consecutive eugonadal male AI patients and 38 healthy matched control subjects. Patients were subdivided according to the presence or absence of SH (group SH+ and group SH-, respectively). Mean Z-score levels of spinal bone mineral density measured by dual-energy x-ray absorptiometry were lower (P < 0.05) in group SH+ (-0.42 +/- 1.62) in comparison with group SH- (0.6 +/- 1.13) and controls (0.47 +/- 1.06). Thus, in order for the most appropriate management to be individually tailored, bone mass evaluation is strongly indicated in Al male patients with SH, irrespective of their gonadal status.
引用
收藏
页码:5491 / 5494
页数:4
相关论文
共 26 条
[1]
Adrenal incidentaloma: An overview of clinical and epidemiological data from the National Italian Study Group [J].
Angeli, A ;
Osella, G ;
Ali, A ;
Terzolo, M .
HORMONE RESEARCH, 1997, 47 (4-6) :279-283
[2]
Adrenal incidentalomas and glucocorticoid autonomy [J].
Aron, DC .
CLINICAL ENDOCRINOLOGY, 1998, 49 (02) :157-158
[3]
Bone loss rate in adrenal incidentalomas: A longitudinal study [J].
Chiodini, I ;
Torlontano, M ;
Carnevale, V ;
Guglielmi, G ;
Cammisa, M ;
Trischitta, V ;
Scillitani, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5337-5341
[4]
Adrenal mass [J].
Cook, DM .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1997, 26 (04) :829-&
[5]
Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence? [J].
Devogelaer, JP .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) :237-239
[6]
EDITORIAL - A-I-D-S - THE NEW ENDOCRINE EPIDEMIC [J].
GRIFFING, GT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1530-1531
[7]
GUGLIELMI G, 1995, EUR RADIOL, V5, P269
[8]
INCIDENTALLY DISCOVERED ADRENAL MASSES [J].
KLOOS, RT ;
GROSS, MD ;
FRANCIS, IR ;
KOROBKIN, M ;
SHAPIRO, B .
ENDOCRINE REVIEWS, 1995, 16 (04) :460-484
[9]
Normal reference laboratory values [J].
Kratz, A ;
Lewandrowski, KB .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1063-1072
[10]
The assessment of bone mass in men [J].
Lombardi, A ;
Ross, PD .
CALCIFIED TISSUE INTERNATIONAL, 2001, 69 (04) :222-224